Javascript must be enabled to continue!
Potentiation of the depressor effect of acetylcholine by carvedilol
View through CrossRef
Carvedilol, a beta‐1,2 and alpha‐1 adrenoceptor blocker was explored in anesthetized rats in which systolic pressure was measured to determine if it enhances the vasodilator effect of single doses of acetylcholine (0.1, 0.15, 0.2, 0.25, 0.5 ug) by enhancing the availability of nitric oxide. At a maximal cumulative dose(1.364±0.228mg/kg) carvedilol potentiated the depressor effect of acetylcholine by 32‐15% (lowest to highest dose, P<0.01‐0.001). This effect was annulled by prevention of nitric oxide synthesis with nitro‐L‐arginine (15mg/kg) and restoration of the baseline systolic pressure with an infusion of nitroglycerin, a nitric oxide donor. Giving this treatment before carvedilol also prevented its potentiation of acetylcholine effect. Carvedilol may partly enhance the depressor effect of acetylcholine by annulling the reflexly‐mediated sympathetic compensation for the hypotension through its alpha‐1 adrenoceptor blockade. Pretreatment with phenoxybenzamine, a blocker of alpha‐1,2 adrenoceptors and an infusion of angiotensin II to restore basal systolic pressure to baseline had minimal effect on the depressor action of acetylcholine. This was also true with pretreatment with propranolol. It is concluded that carvedilol potentiated the depressor effect of acetylcholine essentially by enhancing the synthesis of nitric oxide. Supported by the American University of Beirut.
Title: Potentiation of the depressor effect of acetylcholine by carvedilol
Description:
Carvedilol, a beta‐1,2 and alpha‐1 adrenoceptor blocker was explored in anesthetized rats in which systolic pressure was measured to determine if it enhances the vasodilator effect of single doses of acetylcholine (0.
1, 0.
15, 0.
2, 0.
25, 0.
5 ug) by enhancing the availability of nitric oxide.
At a maximal cumulative dose(1.
364±0.
228mg/kg) carvedilol potentiated the depressor effect of acetylcholine by 32‐15% (lowest to highest dose, P<0.
01‐0.
001).
This effect was annulled by prevention of nitric oxide synthesis with nitro‐L‐arginine (15mg/kg) and restoration of the baseline systolic pressure with an infusion of nitroglycerin, a nitric oxide donor.
Giving this treatment before carvedilol also prevented its potentiation of acetylcholine effect.
Carvedilol may partly enhance the depressor effect of acetylcholine by annulling the reflexly‐mediated sympathetic compensation for the hypotension through its alpha‐1 adrenoceptor blockade.
Pretreatment with phenoxybenzamine, a blocker of alpha‐1,2 adrenoceptors and an infusion of angiotensin II to restore basal systolic pressure to baseline had minimal effect on the depressor action of acetylcholine.
This was also true with pretreatment with propranolol.
It is concluded that carvedilol potentiated the depressor effect of acetylcholine essentially by enhancing the synthesis of nitric oxide.
Supported by the American University of Beirut.
Related Results
Carvedilol ameliorates experimental atherosclerosis by inhibiting the NLRP3 inflammasome
Carvedilol ameliorates experimental atherosclerosis by inhibiting the NLRP3 inflammasome
Abstract
Objective: To investigate the protective effect of carvedilol against atherosclerosis by inhibiting the NLRP3 inflammasome.
Methods:In vitro experiments, human umb...
Differing Beta-Blocking Effects of Carvedilol and Metoprolol
Differing Beta-Blocking Effects of Carvedilol and Metoprolol
Abstract
Background
Metoprolol is a beta1-selective beta-adrenergic antagonist while carvedilol is a non-selective beta-b...
The dose dependency of the alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol in man.
The dose dependency of the alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol in man.
1. The alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol, a beta‐adrenoceptor antagonist with vasodilating properties, and labetalol were investigated in 10 healthy ma...
Effect of Lercanidipine on the Pharmacokinetics‐Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease
Effect of Lercanidipine on the Pharmacokinetics‐Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease
AbstractThis study evaluates the carvedilol‐lercanidipine drug interaction, and the influence of chronic kidney disease (CKD) on both drugs. Patients with high blood pressure (8 wi...
Improvement in Thrombocytopenia after Carvedilol use in Hepatitis C cirrhotic patients.
Improvement in Thrombocytopenia after Carvedilol use in Hepatitis C cirrhotic patients.
Carvedilol is a β-blocker (non-selective). It causes vasoconstriction in the splanchnic vessels and causes reduction of portal inflow. Hence this change causes less destruction of ...
Carvedilol Versus Propranolol in the Prevention of Variceal Rebleeding in Hepatic Schistosomiasis: Efficacy and Safety
Carvedilol Versus Propranolol in the Prevention of Variceal Rebleeding in Hepatic Schistosomiasis: Efficacy and Safety
Abstract
Background: The betablockers combined with endoscopic variceal band ligation (EVL) is the most effective prevention of variceal rebleeding. The aim of this study i...
Evaluation of the Effect of Carvedilol in Preventing Right Ventricular Dysfunction in Breast Cancer Patients Receiving Anthracycline
Evaluation of the Effect of Carvedilol in Preventing Right Ventricular Dysfunction in Breast Cancer Patients Receiving Anthracycline
Background:
Today, it has been shown that it is possible for right ventricular (RV) wall motion abnormalities or RV functional disorders to occur during cancer treatmen...
Effect Of Vasodilatory β‐Adrenoceptor Blockers On Cardiovascular Haemodynamics In Anaesthetized Rats
Effect Of Vasodilatory β‐Adrenoceptor Blockers On Cardiovascular Haemodynamics In Anaesthetized Rats
SUMMARY1. The effect of vasodilatory β‐adrenoceptor blockers on regional blood flow in the major organs of anaesthetized rats was investigated using radioactive microspheres. The a...

